Millennium Management’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-50,038
| Closed | -$68.1K | – | 3963 |
|
|
2025
Q1 | $68.1K | Sell |
50,038
-159,328
| -76% | -$217K | ﹤0.01% | 3794 |
|
|
2024
Q4 | $289K | Sell |
209,366
-188,559
| -47% | -$260K | ﹤0.01% | 3522 |
|
|
2024
Q3 | $426K | Sell |
397,925
-128,427
| -24% | -$137K | ﹤0.01% | 3388 |
|
|
2024
Q2 | $1.13M | Buy |
526,352
+429,438
| +443% | +$923K | ﹤0.01% | 2805 |
|
|
2024
Q1 | $315K | Buy |
96,914
+57,240
| +144% | +$186K | ﹤0.01% | 3484 |
|
|
2023
Q4 | $813K | Buy |
+39,674
| New | +$813K | ﹤0.01% | 2944 |
|
|
2023
Q3 | – | Sell |
-24,242
| Closed | -$206K | – | 4143 |
|
|
2023
Q2 | $206K | Buy |
+24,242
| New | +$206K | ﹤0.01% | 3694 |
|
|
2022
Q2 | – | Sell |
-74,238
| Closed | -$1.12M | – | 5062 |
|
|
2022
Q1 | $1.12M | Buy |
+74,238
| New | +$1.12M | ﹤0.01% | 3504 |
|